Physician profile
Pushplata Siroya
NPI 1962462390
$1,187.05
in general payments reported to CMS, 2019-2025
6 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.13 · 2020: $32.22 · 2021: $27.78 · 2022: $29.79 · 2024: $24.53 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $856 · Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $855.58 |
| Food and Beverage | $203.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,050.50 | 2022-2025 | Minimed 780g |
| Merck Sharp & Dohme LLC | $43.19 | 2020-2024 | |
| Amgen INC. | $41.67 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $19.76 | 2019 | |
| Abbvie INC. | $18.37 | 2019 | |
| Novo Nordisk INC | $13.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pushplata Siroya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.